izokibep
izokibep: sourced relationships with 1 company · 3 clinical trials tracked.
izokibep evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could izokibep → SLRN affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| ACELYRIN, Inc. (SLRN) Hidradenitis Suppurativa; Psoriatic Arthritis | Phase 3 |
Clinical Trial Registry Records (3)
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa
Primary endpoint: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 12
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Active Psoriatic Arthritis
Primary endpoint: Number of Participants Who Achieved 50% Improvement in American College of Rheumatology (ACR50) at Week 16
A Phase 2b Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa
Primary endpoint: Part A: Number of Participants Who Achieved Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 12
Frequently asked questions
Which companies have sourced relationships with izokibep?
izokibep has dated SEC/FDA relationship records for ACELYRIN, Inc..
How many clinical trials involve izokibep?
BioSniper tracks 3 clinical trials involving izokibep.